Cure for Hypertension

(259 customer reviews)

Our Vaccines business has a portfolio of 41 paediatric, adolescent, adult, other people and travel vaccines that offer protection against 22 different diseases. We have a pipeline of 14 candidate vaccines in early, mid and late stage development against a range of diseases. Our pipeline of potential new vaccines covers many of the diseases still having a serious impact around the world, including malaria, HIV, TB and Ebola. In 2016, the business contributed £4.6 billion (16%) to the overall turnover of the Group.